2m 2m 2m 2m 2m 2m 2m
ADMA Biologics (ADMA)
NASDAQ
$13.34+$0.15 (+1.10%)
Price as of Nov 12, 2026 10:02 AM EST- $2.9BMarket Cap
- -19.87%1-Year Change
- BiotechnologyIndustry
ADMA Biologics (ADMA)
$13.34+$0.15 (+1.10%)
ADMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.19 | ||
Change | +$0.52 (+4.10%) | ||
Open | $12.71 | ||
High | $13.28 | ||
Low | $12.60 | ||
Previous Close | $12.67 | ||
Volume | 2,564,586 | ||
30-Day Average Volume | 3,894,863 | ||
1-Week Change | 25.86% | ||
1-Month Change | 27.32% | ||
1-Year Change | -19.87% | ||
3-Year Change | 249.87% | ||
5-Year Change | 729.56% | ||
Fundamentals | |||
Shares Outstanding | 221.9M | ||
Total Assets | $732.5M | ||
Market Cap | $2.9B | ||
Enterprise Value | $3.0B | ||
Period: QTR TTM FY | |||
Revenue | $141.1M | ||
Net Income | $49.9M | ||
Free Cash Flow | $15.4M | ||
EBIT | $65.6M | ||
EBITDA | $67.4M | ||
Net Working Capital | $480.6M | ||
EPS | $0.22 | ||
Enterprise Value/EBITDA | 44 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 7 | ||
P/E | 60 | ||
PEG | 2 | ||
Price/Free Cash Flow | 190 | ||
Price/Operating Cash Flow | 168 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue